Register
Login:
Share:
Email Facebook Twitter


EXCLUSIVE: Ascent Resources ask shareholders for ability to raise funds


Clinigen Share Price (CLIN)



Share Price Information for Clinigen (CLIN)


Share Price: 916.00Bid: 918.00Ask: 921.00Change: -9.00 (-0.97%)Faller - Clinigen
Spread: 3.00Spread as %: 0.33%Open: 923.00High: 935.00Low: 912.00Yesterday’s Close: 925.00

Clinigen Group Plc Ord 0.1P

Clinigen is listed in the FTSE AIM 100, FTSE AIM UK 50, FTSE AIM All-Share
Clinigen is part of the Household Utilities sector






Share Price SpacerPrice
916.00
Share Price SpacerBid
918.00
Share Price SpacerAsk
921.00
Share Price SpacerChange
-0.97%-9.00
Share Price SpacerVolume
605,010
Share Price SpacerOpen
923.00
Share Price SpacerHigh
935.00
Share Price SpacerLow
912.00
Share Price SpacerClose
925.00
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 132.19m £1,210.87m 2,000

52 Week High 1,116.00 52 Week High Date 23-JAN-2018
52 Week Low 777.00 52 Week Low Date 11-OCT-2018

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
615 116,251 53,428 40.000 22.90 4.30 0.47


London South East Users info for Clinigen




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

13-Nov-18
17:44:35
922.592
46
Buy* 
918.00
921.00
424.39
Trade Type:
Ordinary

13-Nov-18
17:39:38
919.466
238
Sell* 
918.00
921.00
2,188
Trade Type:
Ordinary

13-Nov-18
17:30:06
915.716
1,979
Sell* 
918.00
921.00
18.12k
Trade Type:
Ordinary




View more Clinigen trades >>

Directors Deals for Clinigen (CLIN)
Trade DateActionNotifierPriceCurrencyAmountHolding
01-Oct-18Placing
Trade Notifier Information for Clinigen Group
Shaun Edward Chilton held the position of CEO at Clinigen Group at the time of this trade.
 Shaun Edward Chilton
845GBX7,101320044
01-Oct-18Placing
Trade Notifier Information for Clinigen Group
Anne Hyland held the position of Non-Executive Director at Clinigen Group at the time of this trade.
 Anne Hyland
845GBX4,1420
23-Nov-17Sell
Trade Notifier Information for Clinigen Group
Chris Rigg held the position of Executive Director at Clinigen Group at the time of this trade.
 Chris Rigg
1017GBX4,9551608
View more Clinigen directors dealings >>


CrystalBallBroke
Posts: 1,501
Opinion:No Opinion
Price:905.50
RE: this is
1 Nov '18
the only reason i would consider investing any more money here, is to drop my average to a figure closer to the realistic value of this company, and thus a much lower number than it currently is, thus giving me a chance of getting out at break even overall.
robins
Posts: 1,519
Opinion:No Opinion
Price:866.50
Re: Quantum
16 Oct '18
As long as Chris Rigg is happy so am I. Not.
finnharps1
Posts: 1,294
Opinion:No Opinion
Price:866.50
this is
16 Oct '18
still a strong hold...not sure how long it will be before we get back up to £10 territory but it will happen.......If I had funds I would have bought more............Im still a believer. ATB
rylidan
Posts: 1,535
Opinion:No Opinion
Price:858.50
RE: Quantum
16 Oct '18
Also the profit from Quantum could be down to the synergy savings and the sales outlets that Clinigen has worldwide. Should end up beind good for all including Quantum shareholders who still hold.
rylidan
Posts: 1,535
Opinion:No Opinion
Price:857.00
RE: Quantum
16 Oct '18
Mind you I do agree we were oversold on the results, which I thought were good. The fact stands that at this share price, they got Quantum at a steal, and ths results confirmed that.
View more share chat for Clinigen (CLIN) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.